Billions Spent for …

“It appears that advances in diabetes care over the past decade have not translated into meaningful improvement in population-level treatment outcomes.” These are not our words although we have said something very similar, no these words come from a study published in JAMA Internal Medicine Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016 by Pooyan Kazemian, PhD; Fatma M. Shebl, MD, PhD; Nicole McCann, BA; et al.

The authors conclude:

“It appears that the diabetes care cascade in the United States has not significantly improved between 2005 and 2016. This study . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

© 2005 - 2019 Diabetic Investor, Inc., all rights reserved. Unless expressly permitted under your written license agreement, you are not authorized to forward or to otherwise copy our newsletter, or any portion thereof, by electronic means or otherwise. 17 U.S.C. §504 provides for statutory damages of up to $150,000 per infringement of a copyright and additional damages.